Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Anna Zampetaki(King's College London), Manuel Mayr(Lung Institute), Stefan Kiechl(Innsbruck Medical University), Marianna Prokopi(Cyprus University of Technology), Siegfried Weger(University of Verona), Chantal M. Boulanger(Inserm), Ignat Drozdov(ING Direct), Agnes Mayr(University of Verona), Phil Chowienczyk(King's College London), Georg Schett(Karolinska University Hospital), Ajay M. Shah(University of Wales), Lindsey Tilling(King's College London), Peter Willeit(Innsbruck Medical University), Jean–Marie Renard(Délégation Paris 5), Johann Willeit(Innsbruck Medical University)
Cited by 463
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
|Proceedings of the National Academy of Sciences|2010|1.6k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k